10x Genomics Inc (NAS:TXG)
$ 24.76 -0.07 (-0.28%) Market Cap: 2.96 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.12 GF Score: 75/100

10X Genomics Inc at JPMorgan Healthcare Conference Transcript

Jan 09, 2023 / 03:30PM GMT
Release Date Price: $40.03 (+5.96%)
Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst

All right. Good morning, everyone. Welcome to day 1 of the JPMorgan Healthcare Conference. I'm Julia Qin, lead analyst covering life science tools and diagnostics at JPMorgan and it's my great pleasure to introduce you to our very first presentation today by 10x Genomics.

So we'll do 20 minutes of presentation and 20 minutes of Q&A. (Operator Instructions)

And with that, let me turn it over to Serge.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thank you, Julia. Thank you. It's great to be back here in person.

Before we begin, I want to point out our safe harbor statement on Slide 2 and invite you to visit our website for additional disclosures regarding forward-looking statements made today.

So as I stand here today, we're in a great position. We have a large revenue base, rapid growth to get here. Thousands of instruments installed around the world, strong employee base, a formidable intellectual property estate and thousands of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot